Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita Raddatz

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Protocols in Pharmacology|February 2, 2012
Practical aspects of radioligand bindingMichael McKinney, Rita Raddatz
Current Protocols in Pharmacology|February 2, 2012
Receptors as drug targetsMichael Williams, Rita Raddatz
Biochemical Pharmacology|June 19, 2007
Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessmentRita Raddatz, Hervé Schaffhauser, Michael J Marino
Current Topics in Medicinal Chemistry|February 20, 2010
Histamine H3 antagonists for treatment of cognitive deficits in CNS diseasesRita Raddatz, Ming Tao, Robert L Hudkins
Bioorganic & Medicinal Chemistry Letters|September 13, 2011
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonistsMing Tao, Rita Raddatz, Lisa D Aimone, et al.
Chemical Biology & Drug Design|December 5, 2012
From an atypical wake-promoting agent to potent histamine-3 receptor inverse agonistsDerek Dunn, Rita Raddatz, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2012
Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonistsKurt A Josef, Lisa D Aimone, Jacquelyn Lyons, et al.
Journal of Medicinal Chemistry|November 24, 2011
Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activityMing Tao, Lisa D Aimone, Zeqi Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonistsReddeppa Reddy Dandu, Jacquelyn A Lyons, Rita Raddatz, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Amine-constrained pyridazinone histamine H₃ receptor antagonistsBabu G Sundar, Thomas Bailey, Edward Bacon, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Protocols in Pharmacology|February 2, 2012
Practical aspects of radioligand bindingMichael McKinney, Rita Raddatz
Current Protocols in Pharmacology|February 2, 2012
Receptors as drug targetsMichael Williams, Rita Raddatz
Biochemical Pharmacology|June 19, 2007
Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessmentRita Raddatz, Hervé Schaffhauser, Michael J Marino
Current Topics in Medicinal Chemistry|February 20, 2010
Histamine H3 antagonists for treatment of cognitive deficits in CNS diseasesRita Raddatz, Ming Tao, Robert L Hudkins
Bioorganic & Medicinal Chemistry Letters|September 13, 2011
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonistsMing Tao, Rita Raddatz, Lisa D Aimone, et al.
Chemical Biology & Drug Design|December 5, 2012
From an atypical wake-promoting agent to potent histamine-3 receptor inverse agonistsDerek Dunn, Rita Raddatz, Mark A Ator, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2012
Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonistsKurt A Josef, Lisa D Aimone, Jacquelyn Lyons, et al.
Journal of Medicinal Chemistry|November 24, 2011
Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activityMing Tao, Lisa D Aimone, Zeqi Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonistsReddeppa Reddy Dandu, Jacquelyn A Lyons, Rita Raddatz, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Amine-constrained pyridazinone histamine H₃ receptor antagonistsBabu G Sundar, Thomas Bailey, Edward Bacon, et al.
Pageof 3